Total Valuation
Surgery Partners has a market cap or net worth of €1.52B. The enterprise value is €7.80K.
Market Cap€1.52B
Enterprise Value€7.80K
Share Statistics
Surgery Partners has 130,918,260 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding130,918,260
Owned by Insiders1.73%
Owned by Institutions3.90%
Financial Efficiency
Surgery Partners’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is 4.24%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)4.24%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee206.79K
Profits Per Employee6.18K
Employee Count16,000
Asset Turnover0.40
Inventory Turnover26.33
Valuation Ratios
The current PE Ratio of Surgery Partners is ―. Surgery Partners’s PEG ratio is 0.47.
PE Ratio―
PS Ratio0.59
PB Ratio1.15
Price to Fair Value1.15
Price to FCF10.05
Price to Operating Cash Flow6.62
PEG Ratio0.47
Income Statement
In the last 12 months, Surgery Partners had revenue of 3.31B and earned -77.90M in profits. Earnings per share was -0.61.
Revenue3.31B
Gross Profit765.00M
Operating Income389.50M
Pretax Income116.90M
Net Income-77.90M
EBITDA565.50M
Earnings Per Share (EPS)-0.61
Cash Flow
In the last 12 months, operating cash flow was 258.00M and capital expenditures -70.40M, giving a free cash flow of 187.60M billion.
Operating Cash Flow258.00M
Free Cash Flow187.60M
Free Cash Flow per Share1.43
Dividends & Yields
Surgery Partners pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-37.91%
50-Day Moving Average12.69
200-Day Moving Average12.44
Relative Strength Index (RSI)37.90
Average Volume (3m)0.00
Important Dates
Surgery Partners upcoming earnings date is Nov 10, 2026, Before Open (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 10, 2026
Ex-Dividend Date―
Financial Position
Surgery Partners as a current ratio of 1.87, with Debt / Equity ratio of 240.47%
Current Ratio1.87
Quick Ratio1.71
Debt to Market Cap1.43
Net Debt to EBITDA6.69
Interest Coverage Ratio1.43
Taxes
In the past 12 months, Surgery Partners has paid 18.00M in taxes.
Income Tax18.00M
Effective Tax Rate0.15
Enterprise Valuation
Surgery Partners EV to EBITDA ratio is 10.17, with an EV/FCF ratio of 29.40.
EV to Sales1.74
EV to EBITDA10.17
EV to Free Cash Flow29.40
EV to Operating Cash Flow20.96
Balance Sheet
Surgery Partners has €216.70M in cash and marketable securities with €4.02B in debt, giving a net cash position of -€3.80B billion.
Cash & Marketable Securities€216.70M
Total Debt€4.02B
Net Cash-€3.80B
Net Cash Per Share-€29.03
Tangible Book Value Per Share-€13.43
Margins
Gross margin is 21.37%, with operating margin of 11.77%, and net profit margin of -2.35%.
Gross Margin21.37%
Operating Margin11.77%
Pretax Margin3.53%
Net Profit Margin-2.35%
EBITDA Margin17.09%
EBIT Margin11.77%
Analyst Forecast
The average price target for Surgery Partners is €16.11, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€16.11
Price Target Upside35.40% Upside
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast-3.07%
EPS Growth Forecast55.61%